AstraZeneca - VAI
FDA Inspections Database
AstraZeneca - VAI
FDA Inspections Database
U.S. FDA inspection classifications and citation records from the official FDA inspection database.
- Total Records 31
- Latest Inspection 2024-05-31
- Data Source U.S. FDA
- Last Updated 2024-08-15
Company Overview
Company
AstraZeneca - VAI
Country
United Kingdom
Website
Social Profiles
Company Snapshot
AstraZeneca - VAI
2 Kingdom Street, Paddington, London W2 6BD
United Kingdom
www.astrazeneca.com/ Russell.Gantt@astrazeneca.com View on MapFDA Inspections Timeline (31 records)
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2024-05-31
FMD Date
2024-08-15
Fiscal Year
2024
State
Maryland
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2024
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2023-09-19
FMD Date
2023-12-15
Fiscal Year
2023
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2023
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2023-01-19
FMD Date
2023-03-15
Fiscal Year
2023
State
Maryland
Location
Frederick, Maryland, United States
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2022-12-01
FMD Date
-
Fiscal Year
2023
State
Additional Details
Mutual Recognition Agreement (MRA)
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2022-12-01
FMD Date
-
Fiscal Year
2023
State
Additional Details
Mutual Recognition Agreement (MRA)
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
Yes
Inspection End Date
2022-07-22
FMD Date
2022-10-20
Fiscal Year
2022
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2022
Citations: Yes
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-12-06
FMD Date
2021-06-14
Fiscal Year
2020
State
Additional Details
Mutual Recognition Agreement (MRA)
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2020
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-10-11
FMD Date
2020-07-21
Fiscal Year
2020
State
Additional Details
Mutual Recognition Agreement (MRA)
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2020
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-08-30
FMD Date
2019-10-16
Fiscal Year
2019
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2019
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2018-08-17
FMD Date
2018-11-05
Fiscal Year
2018
State
Maryland
Location
Frederick, Maryland, United States
Inspection Info
Fiscal Year: 2018
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
No
Inspection End Date
2018-06-20
FMD Date
2019-04-05
Fiscal Year
2018
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2018
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2018-01-30
FMD Date
2019-03-25
Fiscal Year
2018
State
Maryland
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2018
Citations: Yes
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-12-07
FMD Date
2020-01-22
Fiscal Year
2018
State
Additional Details
Mutual Recognition Agreement (MRA)
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2018
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2017-02-07
FMD Date
2017-05-15
Fiscal Year
2017
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2017
Citations: Yes
Legal Name
AstraZeneca LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2016-04-27
FMD Date
-
Fiscal Year
2016
State
Massachusetts
Location
Westborough, Massachusetts, United States
Inspection Info
Fiscal Year: 2016
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2016-02-26
FMD Date
-
Fiscal Year
2016
State
California
Location
Redwood City, California, United States
Inspection Info
Fiscal Year: 2016
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
No
Inspection End Date
2015-05-20
FMD Date
-
Fiscal Year
2015
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-03-28
FMD Date
2014-06-19
Fiscal Year
2014
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-10-25
FMD Date
-
Fiscal Year
2014
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
No
Inspection End Date
2013-05-22
FMD Date
-
Fiscal Year
2013
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2013
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2013-03-20
FMD Date
-
Fiscal Year
2013
State
Maryland
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2013
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2011-10-28
FMD Date
-
Fiscal Year
2012
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2012
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
No
Inspection End Date
2011-05-03
FMD Date
-
Fiscal Year
2011
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
AstraZeneca LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2011-04-27
FMD Date
-
Fiscal Year
2011
State
Massachusetts
Location
Westborough, Massachusetts, United States
Inspection Info
Fiscal Year: 2011
Citations: Yes
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-12-10
FMD Date
2011-07-14
Fiscal Year
2011
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-11-10
FMD Date
-
Fiscal Year
2011
State
Delaware
Additional Details
Sponsor, Contract Research Organization
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
Yes
Inspection End Date
2010-06-23
FMD Date
-
Fiscal Year
2010
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2010
Citations: Yes
Legal Name
AstraZeneca LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2010-05-17
FMD Date
-
Fiscal Year
2010
State
Massachusetts
Location
Westborough, Massachusetts, United States
Inspection Info
Fiscal Year: 2010
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-03-31
FMD Date
-
Fiscal Year
2010
State
Delaware
Additional Details
Sponsor, Contract Research Organization
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
Yes
Inspection End Date
2009-12-07
FMD Date
-
Fiscal Year
2010
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2010
Citations: Yes
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
Yes
Inspection End Date
2009-06-16
FMD Date
-
Fiscal Year
2009
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2009
Citations: Yes
Classification Breakdown
31 total- VAI (Voluntary Action Indicated)
Official Source
All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.
Visit FDA.govRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2024
Citations: Yes
100% Official Data
Directly from the U.S. FDA inspection database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.